IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

[1]  Jianming Tan,et al.  IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9 , 2014, Molecular Cancer.

[2]  A. Bougdour,et al.  A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation , 2013, The Journal of experimental medicine.

[3]  R. Ramesh,et al.  Mitogen-activated protein kinases and their role in radiation response. , 2013, Genes & cancer.

[4]  Lukas D. Osborne,et al.  HIF1α and HIF2α independently activate SRC to promote melanoma metastases. , 2013, The Journal of clinical investigation.

[5]  M. Heur,et al.  Interleukin‐1β enhances cell migration through AP‐1 and NF‐κB pathway‐dependent FGF2 expression in human corneal endothelial cells , 2013, Biology of the cell.

[6]  P. Argani,et al.  EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis , 2013, Breast Cancer Research and Treatment.

[7]  A. Paller,et al.  Deacetylated GM3 Promotes uPAR-Associated Membrane Molecular Complex to Activate p38 MAPK in Metastatic Melanoma , 2013, Molecular Cancer Research.

[8]  D. Park,et al.  S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells , 2013, Molecules and cells.

[9]  N. D’Silva,et al.  Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6 , 2013, Clinical Cancer Research.

[10]  J. Magdalou,et al.  Regulation of Xylosyltransferase I Gene Expression by Interleukin 1β in Human Primary Chondrocyte Cells , 2012, The Journal of Biological Chemistry.

[11]  Do-Hee Kim,et al.  Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. , 2012, Biochemical pharmacology.

[12]  Wei Liu,et al.  Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion , 2012, Molecular Cancer.

[13]  Wun-Jae Kim,et al.  Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells. , 2012, International journal of molecular medicine.

[14]  Himanshi Bhatia,et al.  Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1β in human pancreatic cancer cells: role of JNK. , 2012, Cancer letters.

[15]  Bow Ho,et al.  Persistent Helicobacter pylori Specific Th17 Responses in Patients with Past H. pylori Infection Are Associated with Elevated Gastric Mucosal IL-1β , 2012, PloS one.

[16]  K. Gallo,et al.  MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis. , 2012, Cancer research.

[17]  L. Qin,et al.  Inflammatory Immune Responses in Tumor Microenvironment and Metastasis of Hepatocellular Carcinoma , 2012, Cancer Microenvironment.

[18]  D. Spandidos,et al.  The tumor microenvironment in hepatocellular carcinoma (review). , 2012, International journal of oncology.

[19]  Nicole S. Bryce,et al.  p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells , 2012, Journal of Neuro-Oncology.

[20]  A. Risco,et al.  New Insights into the p38γ and p38δ MAPK Pathways , 2011, Journal of signal transduction.

[21]  Qiaojia Huang,et al.  Akt2 Kinase Suppresses Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)-mediated Apoptosis in Ovarian Cancer Cells via Phosphorylating GAPDH at Threonine 237 and Decreasing Its Nuclear Translocation* , 2011, The Journal of Biological Chemistry.

[22]  B. Kreike,et al.  p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer. , 2011, Neoplasia.

[23]  G. Mills,et al.  Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression , 2011, Oncogene.

[24]  T. Meshel,et al.  Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition , 2011, BMC Cancer.

[25]  S. Hill,et al.  Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway , 2010, Breast Cancer Research.

[26]  Ming Yan,et al.  Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma , 2010, BMC Cancer.

[27]  A. Cuadrado,et al.  Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.

[28]  C. Asselin,et al.  Constitutively active MEK1 is sufficient to induce epithelial‐to‐mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis , 2009, International journal of cancer.

[29]  Zhon-Yin Zhang,et al.  PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. , 2009, Biochemistry.

[30]  Qiaojia Huang,et al.  Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology , 2008, Journal of Cancer Research and Clinical Oncology.

[31]  Jin-Ming Yang,et al.  EMMPRIN Expression as a Prognostic Factor in Radiotherapy of Cervical Cancer , 2008, Clinical Cancer Research.

[32]  Yi-Hsien Hsieh,et al.  p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. , 2007, Cancer research.

[33]  B. Su,et al.  MEKK3 is essential for lipopolysaccharide‐induced interleukin‐6 and granulocyte–macrophage colony‐stimulating factor production in macrophages , 2007, Immunology.

[34]  Y. Itahana,et al.  Reduction of Human Metastatic Breast Cancer Cell Aggressiveness on Introduction of Either Form A or B of the Progesterone Receptor and Then Treatment with Progestins , 2004, Cancer Research.

[35]  B. Su,et al.  Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3 , 2004, Nature Immunology.

[36]  D. Neal,et al.  MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion , 2003, Oncogene.

[37]  Y. Sun,et al.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.

[38]  Philip R. Cohen,et al.  Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases , 1997, The EMBO journal.